Prestige Consumer Healthcare Inc.

PBH Healthcare Drug Manufacturers Specialty & Generic

Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025.

Revenue
+22.7%
EPS
−38.4%
Free cash flow
−38.2%
Total debt
+100.9%

Quarter to September 2026, against a year earlier

42.69 1.63 −3.68%
Market cap
$2.1B
P/E
13.7×
Fwd P/E
11.7×
Dividend yield
—
F-score
5/9
Altman Z
2.48
Beneish M
−2.53
Dividend safety
n/a

Prestige Consumer Healthcare Inc. (PBH) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Prestige Consumer Healthcare Inc. (PBH) trades at a EV/FCF of 19.2×. Over the past ten years it has ranged from 12.6× (September 2015) to 35.9× (April 2017); the current reading is higher than 56% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2026 15.5× (27.25%)
FY2025 21.4× 9.83%
FY2024 19.5× (2.41%)
FY2023 19.9× 20.97%
FY2022 16.5× (4.35%)
FY2021 17.2× (0.52%)
FY2020 17.3× (6.40%)
FY2019 18.5× (1.78%)
FY2018 18.8× (46.20%)
FY2017 35.0× 37.00%

Quarterly newest first

Period EV/FCF Change
Sep 2026 19.5× 9.28%
Jun 2026 17.8× 14.54%
Mar 2026 15.5× 5.03%
Dec 2025 14.8× (4.61%)
43 more quarters

Against its own ten years

Low 12.6× High 35.9×
Ten-year median 18.8×
Current reading's percentile 52

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on PBH